DE1493649A1 - Verfahren zur Herstellung adrenocorticotrop wirksamer Peptide - Google Patents
Verfahren zur Herstellung adrenocorticotrop wirksamer PeptideInfo
- Publication number
- DE1493649A1 DE1493649A1 DE19631493649 DE1493649A DE1493649A1 DE 1493649 A1 DE1493649 A1 DE 1493649A1 DE 19631493649 DE19631493649 DE 19631493649 DE 1493649 A DE1493649 A DE 1493649A DE 1493649 A1 DE1493649 A1 DE 1493649A1
- Authority
- DE
- Germany
- Prior art keywords
- gly
- arg
- tyr
- formula
- val
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims description 14
- 238000000034 method Methods 0.000 title claims description 8
- 102000004196 processed proteins & peptides Human genes 0.000 title claims description 7
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 230000003023 adrenocorticotropic effect Effects 0.000 title claims 2
- 239000002253 acid Substances 0.000 claims description 4
- 125000006239 protecting group Chemical group 0.000 claims description 4
- 238000005903 acid hydrolysis reaction Methods 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 229960000258 corticotropin Drugs 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 102400000739 Corticotropin Human genes 0.000 description 8
- 101800000414 Corticotropin Proteins 0.000 description 8
- -1 butyloxycarbonyl radical Chemical group 0.000 description 8
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000007853 buffer solution Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 3
- 239000005695 Ammonium acetate Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 229940043376 ammonium acetate Drugs 0.000 description 3
- 235000019257 ammonium acetate Nutrition 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- WPWHSFAFEBZWBB-UHFFFAOYSA-N 1-butyl radical Chemical group [CH2]CCC WPWHSFAFEBZWBB-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 2
- 150000001242 acetic acid derivatives Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000004683 dihydrates Chemical class 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 2
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- IALIDHPAWNTXOK-UHFFFAOYSA-N tricosanal Chemical compound CCCCCCCCCCCCCCCCCCCCCCC=O IALIDHPAWNTXOK-UHFFFAOYSA-N 0.000 description 2
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 244000248349 Citrus limon Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 241000252095 Congridae Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000287107 Passer Species 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000002105 tongue Anatomy 0.000 description 1
- 238000005891 transamination reaction Methods 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/695—Corticotropin [ACTH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/32—Modification to prevent enzymatic degradation
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEF0040498 | 1963-08-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1493649A1 true DE1493649A1 (de) | 1969-11-13 |
Family
ID=7098254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19631493649 Pending DE1493649A1 (de) | 1963-08-16 | 1963-08-16 | Verfahren zur Herstellung adrenocorticotrop wirksamer Peptide |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3388112A (enrdf_load_stackoverflow) |
| AT (1) | AT257852B (enrdf_load_stackoverflow) |
| BE (1) | BE651923A (enrdf_load_stackoverflow) |
| CH (1) | CH441363A (enrdf_load_stackoverflow) |
| DE (1) | DE1493649A1 (enrdf_load_stackoverflow) |
| DK (1) | DK118825B (enrdf_load_stackoverflow) |
| GB (1) | GB1071349A (enrdf_load_stackoverflow) |
| NL (1) | NL6409382A (enrdf_load_stackoverflow) |
| SE (1) | SE311021B (enrdf_load_stackoverflow) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3862928A (en) * | 1969-07-09 | 1975-01-28 | Akzona Inc | Psychopharmacological hexa-peptides containing a d-phenylalanyl residue |
| JPS4826010B1 (enrdf_load_stackoverflow) * | 1969-11-11 | 1973-08-03 | ||
| US3923772A (en) * | 1970-03-16 | 1975-12-02 | Shionogi & Co | (1-{60 -aminoisobutyric acid)-corticotropin peptides |
| CA965777A (en) * | 1970-03-16 | 1975-04-08 | Hideo Otsuka | (1-.alpha.-AMINOISOBUTYRIC ACID)-CORTICOTROPIN PEPTIDES |
| US4089821A (en) * | 1976-03-31 | 1978-05-16 | Armour Pharmaceutical Company | Synthesis of peptide amides |
| IT1204434B (it) * | 1986-01-15 | 1989-03-01 | Alfio Bertolini | Composizioni farmaceutiche comprendenti frammenti di acth per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3259616A (en) * | 1957-02-08 | 1966-07-05 | Ciba Geigy Corp | Polypeptides |
| NL278010A (enrdf_load_stackoverflow) * | 1961-05-04 | 1900-01-01 | ||
| US3164614A (en) * | 1961-05-18 | 1965-01-05 | Parke Davis & Co | New reagents for peptide synthesis |
| US3264280A (en) * | 1961-11-28 | 1966-08-02 | Klaus H Hofmann | Tricosapeptides and intermediates for the preparation thereof |
-
1963
- 1963-08-16 DE DE19631493649 patent/DE1493649A1/de active Pending
-
1964
- 1964-08-11 US US388920A patent/US3388112A/en not_active Expired - Lifetime
- 1964-08-13 CH CH1057164A patent/CH441363A/de unknown
- 1964-08-14 AT AT702664A patent/AT257852B/de active
- 1964-08-14 NL NL6409382A patent/NL6409382A/xx unknown
- 1964-08-14 DK DK403664AA patent/DK118825B/da unknown
- 1964-08-14 SE SE9856/64A patent/SE311021B/xx unknown
- 1964-08-17 BE BE651923A patent/BE651923A/xx unknown
- 1964-08-17 GB GB33572/64A patent/GB1071349A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US3388112A (en) | 1968-06-11 |
| SE311021B (enrdf_load_stackoverflow) | 1969-05-27 |
| NL6409382A (enrdf_load_stackoverflow) | 1965-02-17 |
| AT257852B (de) | 1967-10-25 |
| CH441363A (de) | 1967-08-15 |
| BE651923A (enrdf_load_stackoverflow) | 1965-02-17 |
| GB1071349A (en) | 1967-06-07 |
| DK118825B (da) | 1970-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2937779A1 (de) | Aminosaeurederivate und verfahren zu ihrer herstellung | |
| DE2252157C3 (de) | Zwischenprodukte zur herstellung von insulin, insulin-analogen und -derivaten und verfahren zur herstellung von insulin, insulin analogen und derivaten | |
| DE1493649A1 (de) | Verfahren zur Herstellung adrenocorticotrop wirksamer Peptide | |
| DE2460753A1 (de) | Verfahren zur herstellung von humaninsulin | |
| DE1643345C3 (de) | Glucagonderivat und Verfahren zur Herstellung von Glucagon | |
| DE2463205C2 (de) | Octapeptid und Verfahren zu dessen Herstellung | |
| DE2428412A1 (de) | Verfahren zur herstellung von insulin, insulin-analogen und -derivaten | |
| DE1793086C3 (de) | L-Aspartyl-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-Laspartyl-L-phenylalanin-amid und seine Verwendung als diagnostisches Hilfsmittel bei Rentgenuntersuchungen der Gallenblase | |
| DE2461673A1 (de) | Verbindung mit serumcalciumreduzierender aktivitaet | |
| DE1248059B (de) | Verfahren zur Herstellung bradykininwirksamer Undeca- und Dodecapeptide | |
| DE2137971C3 (de) | Polypeptide und Verfahren zu deren Herstellung | |
| DE2902015C2 (enrdf_load_stackoverflow) | ||
| DE1205546B (de) | Verfahren zur Herstellung neuer Dekapeptide | |
| DE2037697A1 (de) | Biologisch aktive Polypeptide | |
| DE3886656T2 (de) | Lösungssynthese eines Oktapeptids. | |
| DE2441184C2 (de) | Verfahren zur Herstellung des Octapeptids Xenopsin | |
| DE1964798A1 (de) | Neue pharmazeutische Praeparate | |
| AT354657B (de) | Verfahren zur herstellung von neuen dipeptid- -derivaten | |
| DE2727048C2 (de) | 8-Norleucyl-ceruletide | |
| AT227688B (de) | Verfahren zur Herstellung von neuen Derivaten des 1,2,3,4-Tetrahydronaphthyl-2-amins und deren Salzen | |
| DE1668876C3 (de) | N-Acyl geschützte Aminosäuren und Peptide, Verfahren zu ihrer Herstellung und ihre Verwendung bei Peptidsynthesen | |
| DE2423390A1 (de) | Pyroglutamylverbindungen mit antidepressiver wirkung und verfahren zu ihrer herstellung | |
| DE1668977B1 (de) | Verfahren zur Herstellung von Pentachlorphenylestern | |
| DE1965101A1 (de) | Pentadekapeptide mit adrenocorticotroper Wirkung und Verfahren zu ihrer Herstellung | |
| AT239772B (de) | Verfahren zur Herstellung langkettiger Trihydroxamsäuren |